SBIR/STTR Research Award

A Novel Method for Signaling Pathway Analysis

Award identifier 9b4984dc81c4e2c8d4f357e17d716c42368f7b88ddc3dd8db98b019b4f9c5df0Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$146,256

Program and phase

STTR · Phase I

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ADVAITA CORP
Proposal award date
Not reported
Contract end date
Not reported
UEI
Q81XNNYPK5H3
Solicitation number
PHS2009-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): A common challenge in the analysis of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions on various regulatory pathways. Currently, a statistical approach is universally used to identify the most relevant pathways in a given experiment. This approach only considers the set of genes present on each pathway and completely ignores other important biological factors. Here we show that in spite of its general adoption, and independently of the particular model used, this statistical analysis is unsatisfactory, and can often provide incorrect results. Using a systems biology approach, we developed an impact analysis that includes the classical statistics, but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc. Our preliminary work shows that the classical analysis produces both false positives and false negatives while the impact analysis provides biologically meaningful results. In this Phase I application, we are proposing to develop a prototype that would demonstrate the feasibility of a commercial software analysis package based on this novel approach. Our team has a very strong track record as demonstrated by: a large number of citations to our previous publications, a large user-base for our previously developed software (over 5,000 scientists from all 5 continents), and very strong letters of support. 1 PUBLIC HEALTH RELEVANCE: The classical statistical approaches, which are universally used to identify the most relevant biological pathways in a given experiment, only consider the number of di(R)erentially expressed genes on each pathway and completely ignores other important biological factors. However, in spite of its general adoption, these statistical approaches are unsatisfactory, and can often provide incorrect results. We propose a novel signaling pathway analysis that includes the classical statistics, but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

8 SBIR/STTR records share this UEI (2009–2023). Reported award amounts total $7,254,780. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.